![HeartBEATS from Lifelong Learning™ artwork](https://is3-ssl.mzstatic.com/image/thumb/Podcasts126/v4/d6/26/0e/d6260eb6-6bbe-c851-bd3a-1907f9b2960c/mza_9855028879710213755.jpg/100x100bb.jpg)
Chronic Kidney Disease and GLP-1 RAs
HeartBEATS from Lifelong Learning™
English - January 11, 2024 21:03 - 28 minutes - 41.2 MB VideoMedicine Health & Fitness Education Courses sleephealth aha americanheartassociation insomnia sleep sleepapnea Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Cardiovascular Benefits of GLP-1 RAs
Next Episode: Obesity and GLP-1 RAs
Conversation around current considerations for use of GLP-1 RAs in people with type 2 diabetes and chronic kidney disease (CKD). The discussion will include general considerations for management of diabetes in CKD, potential benefits of GLP-1 RA therapy in CKD (e.g., glycemic lowering, CV risk reduction, potential kidney benefits), and a discussion of contemporary guideline recommendations for GLP-1 RA use in this population.
Claim CE and MOC Credit at https://bit.ly/4aNc3t8